TEL AVIV, Israel--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ, TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, will be presenting at the LD Micro Main Event on December 2, 2015. The presentation will take place at 10:00 a.m. PST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.
